Personalised therapeutic approaches to glioblastoma: A systematic review
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2023.1166104
Abstract: Introduction Glioblastoma is the most common and malignant primary brain tumour with median survival of 14.6 months. Personalised medicine aims to improve survival by targeting individualised patient characteristics. However, a major limitation has been application… read more here.
Keywords: glioblastoma systematic; personalised therapeutic; systematic review; therapeutic approaches ... See more keywords
Radiogenomic Predictors of Recurrence in Glioblastoma—A Systematic Review
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm12030402
Abstract: Glioblastoma, as the most aggressive brain tumor, is associated with a poor prognosis and outcome. To optimize prognosis and clinical therapy decisions, there is an urgent need to stratify patients with increased risk for recurrent… read more here.
Keywords: glioblastoma systematic; prognosis; review; radiogenomic predictors ... See more keywords